{"log_id": 5946373997493229761, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 4e-06, "average": 0.998659, "min": 0.991913}, "location": {"width": 728, "top": 199, "height": 39, "left": 181}, "words": "哺乳尚不清楚伊达比星及其代谢物是否经乳汁分泌。建议用本品化疗的母亲避免哺乳"}, {"probability": {"variance": 5.6e-05, "average": 0.995319, "min": 0.982392}, "location": {"width": 83, "top": 284, "height": 25, "left": 184}, "words": "儿童用药"}, {"probability": {"variance": 0, "average": 0.999258, "min": 0.997769}, "location": {"width": 295, "top": 317, "height": 28, "left": 227}, "words": "参见【用法用量】的详细描述"}, {"probability": {"variance": 0, "average": 0.999357, "min": 0.998606}, "location": {"width": 84, "top": 394, "height": 24, "left": 188}, "words": "老年用药"}, {"probability": {"variance": 1.2e-05, "average": 0.997728, "min": 0.989427}, "location": {"width": 296, "top": 425, "height": 32, "left": 228}, "words": "参见【用法用量】的详细描述"}, {"probability": {"variance": 0.000965, "average": 0.976623, "min": 0.910542}, "location": {"width": 127, "top": 500, "height": 28, "left": 194}, "words": "[药物相互作用"}, {"probability": {"variance": 3e-06, "average": 0.998649, "min": 0.99168}, "location": {"width": 807, "top": 526, "height": 38, "left": 224}, "words": "伊达比星是强烈的骨髓抑制剂,如与其他具有相似作用机制的药物组成联合化疗方案可导致骨髓"}, {"probability": {"variance": 4.7e-05, "average": 0.997356, "min": 0.967939}, "location": {"width": 846, "top": 562, "height": 41, "left": 185}, "words": "抑制作用相加。与其他有潜在心脏毒性药物联合化疗时,或者是同时应用其他作用于心脏的药物(如"}, {"probability": {"variance": 2.8e-05, "average": 0.997578, "min": 0.978343}, "location": {"width": 537, "top": 604, "height": 35, "left": 184}, "words": "钙离子通道拮抗剂)时,需要在整个治疗期间严密监测心脏功能"}, {"probability": {"variance": 0.002437, "average": 0.990606, "min": 0.671145}, "location": {"width": 799, "top": 637, "height": 39, "left": 224}, "words": "合并用药所引起的肝肾功能的变化可能会影响伊达比星的代谢、药代动力学、疗效和/或毒性反应"}, {"probability": {"variance": 0.000539, "average": 0.993074, "min": 0.883015}, "location": {"width": 574, "top": 678, "height": 35, "left": 222}, "words": "伊达比星治疗同时或之前的2-3周内进行放疗可导致累加的骨髓抑制"}, {"probability": {"variance": 1e-06, "average": 0.998918, "min": 0.99749}, "location": {"width": 86, "top": 779, "height": 25, "left": 188}, "words": "药物过量"}, {"probability": {"variance": 4e-06, "average": 0.998672, "min": 0.991328}, "location": {"width": 804, "top": 802, "height": 38, "left": 230}, "words": "过大剂量的注射用盐酸伊达比星可能在24小时内引起急性心肌毒性,一至二周内产生严重的骨髓"}, {"probability": {"variance": 9e-06, "average": 0.998153, "min": 0.985501}, "location": {"width": 846, "top": 839, "height": 39, "left": 188}, "words": "抑制。在此期间应加强支持疗法和应用输血,无菌隔离护理等措施。也有报道蒽环类药物过量后引起"}, {"probability": {"variance": 1e-06, "average": 0.998997, "min": 0.99466}, "location": {"width": 823, "top": 876, "height": 39, "left": 188}, "words": "的心力衰竭可于数月后出现。病人应密切观察,一旦出现心力衰竭的症状和体征时应予以相应治疗"}, {"probability": {"variance": 0, "average": 0.999322, "min": 0.998315}, "location": {"width": 83, "top": 960, "height": 24, "left": 204}, "words": "药理毒理"}, {"probability": {"variance": 0.0029, "average": 0.988509, "min": 0.698708}, "location": {"width": 562, "top": 1001, "height": 34, "left": 240}, "words": "伊达比星是一种DNA嵌入剂,作用于拓扑异构酶I,抑制核酸合成"}, {"probability": {"variance": 0.000479, "average": 0.995221, "min": 0.856144}, "location": {"width": 795, "top": 1037, "height": 38, "left": 241}, "words": "蒽环结构4位的改变使该化合物具有高亲脂性,与阿霉素和柔红霉素相比提高了细胞对药物的摄"}, {"probability": {"variance": 0, "average": 0.999645, "min": 0.999645}, "location": {"width": 25, "top": 1091, "height": 22, "left": 191}, "words": "入"}, {"probability": {"variance": 1e-06, "average": 0.999201, "min": 0.995088}, "location": {"width": 746, "top": 1116, "height": 37, "left": 243}, "words": "与柔红霉素相比,伊达比星具有更高的活性,静脉或口服用药对鼠白血病和淋巴瘤均有效"}, {"probability": {"variance": 0.008288, "average": 0.980691, "min": 0.41545}, "location": {"width": 789, "top": 1152, "height": 45, "left": 241}, "words": "人和鼠的体外实验表明,与阿霉素和柔红霉素相比,蒽环类耐药细胞对伊达比星显示出较低程"}, {"probability": {"variance": 3e-06, "average": 0.998556, "min": 0.99463}, "location": {"width": 116, "top": 1206, "height": 27, "left": 192}, "words": "的交叉耐药性"}, {"probability": {"variance": 0.001862, "average": 0.98896, "min": 0.765518}, "location": {"width": 800, "top": 1230, "height": 46, "left": 241}, "words": "动物心脏毒性研究提示伊达比星比阿霉素和柔红霉素具有更高的治疗指数,其主要代谢产物伊达"}, {"probability": {"variance": 1e-06, "average": 0.999142, "min": 0.993692}, "location": {"width": 809, "top": 1273, "height": 38, "left": 196}, "words": "比星醇在体内和体外实验中均显示出抗肿瘤活性。在大鼠实验中,伊达比星醇的心脏毒性明显低"}, {"probability": {"variance": 1e-06, "average": 0.998559, "min": 0.996892}, "location": {"width": 154, "top": 1323, "height": 25, "left": 194}, "words": "同剂量的伊达比星"}, {"probability": {"variance": 2e-06, "average": 0.998962, "min": 0.995436}, "location": {"width": 286, "top": 1361, "height": 26, "left": 231}, "words": "静脉注射给药后,小鼠的LD为4"}, {"probability": {"variance": 0.000593, "average": 0.991355, "min": 0.887205}, "location": {"width": 481, "top": 1351, "height": 35, "left": 561}, "words": "kg大鼠为2.9mg/kg,狗为1.0mg/kg。单剂静脉给药后,主"}, {"probability": {"variance": 9e-06, "average": 0.997846, "min": 0.988888}, "location": {"width": 442, "top": 1395, "height": 33, "left": 194}, "words": "要靶器官为血淋巴系统,尤其在狗还表现为胃肠道"}, {"probability": {"variance": 0.013699, "average": 0.943911, "min": 0.638681}, "location": {"width": 125, "top": 1533, "height": 23, "left": 559}, "words": "第9页,共11页"}, {"probability": {"variance": 1.7e-05, "average": 0.996909, "min": 0.988216}, "location": {"width": 59, "top": 1562, "height": 19, "left": 266}, "words": "201102"}], "language": 3}